STD Diagnostics Market Analysis By Types (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing), By Location Of Testing (Laboratory Testing, Point of Care Testing), By Testing Devices (Laboratory Devices, Point of Care Devices) And Segment Forecasts To 2022

Table of Content

Chapter 1. Methodology and Scope
                    1.1. Research methodology
                    1.2. Research scope & assumption
                    1.3. List of data sources
Chapter 2. Executive Summary
                    2.1. STD diagnostics market - Industry Summary and Key Buying Criteria, 2012 - 2022
Chapter 3. STD Diagnostics Industry Outlook
                    3.1. STD diagnostics market segmentation
                    3.2. STD diagnostics market size and growth prospects, 2012-2022
                    3.3. STD diagnostics market dynamics
                       3.3.1. Market driver analysis
                       3.3.2. Market restraint analysis
                    3.4. Key opportunities prioritized
                    3.5. Industry Analysis - Porter's
                    3.6. STD diagnostics: Company market share, 2014
                    3.7. STD diagnostics market PESTEL analysis, 2014
Chapter 4. STD Diagnostics Types Outlook
                    4.1. STD diagnostics market share by type, 2014 & 2022
                    4.2. Chlamydia testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                    4.3. Syphilis testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                    4.4. Gonorrhea testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                    4.5. Herpes Simplex Virus testing estimates and forecasts, 2012 - 2022 (USD Billion)
                    4.6. Human Papilloma Virus testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                    4.7. Human Immunodeficiency Virus testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                    4.8. Chancroid testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                    4.9. Other devices market estimates and forecasts, 2012 - 2022 (USD Billion)
Chapter 5. STD Diagnostics Location of Testing Outlook
                    5.1. STD diagnostics market share by location of testing, 2014 & 2022
                    5.2. Laboratory testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                       5.2.1. Commercial/Private labs testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                       5.2.2. Public Health Labs testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                    5.3. Point of Care (PoC) testing market estimates and forecasts, 2012 - 2022 (USD Billion)
Chapter 6. STD Diagnostics Testing Devices Outlook
                    6.1. STD diagnostics market share by testing device, 2014 & 2022
                    6.2. Laboratory devices market estimates and forecasts, 2012 - 2022 (USD Billion)
                       6.2.1. Thermal Cyclers - PCR market estimates and forecasts, 2012 - 2022 (USD Billion)
                       6.2.2. Lateral Flow Readers market estimates and forecasts, 2012 - 2022 (USD Billion)
                       6.2.3. Flow Cytometers market estimates and forecasts, 2012 - 2022 (USD Billion)
                       6.2.4. Differential Light Scattering machines market estimates and forecasts, 2012 - 2022 (USD Billion)
                       6.2.5. Absorbance microplate reader - Enzyme-Linked Immunosorbent Assay (ELISA) market estimates and forecasts, 2012 - 2022 (USD Billion)
                       6.2.6. Others market estimates and forecasts, 2012 - 2022 (USD Billion)
                    6.3. Point of Care (PoC) testing market estimates and forecasts, 2012 - 2022 (USD Billion)
                       6.3.1. Phone chips (microfluidics + ICT) market estimates and forecasts, 2012 - 2022 (USD Billion)
                       6.3.2. Portable/bench top/rapid diagnostic kits market estimates and forecasts, 2012 - 2022 (USD Billion)
Chapter 7. STD Diagnostics Regional Outlook
                    7.1. North America
                       7.1.1. North America market, by type, revenue (USD Billion)
                            7.1.1.1. U.S. market estimates and forecasts
                            7.1.1.2. Canada market estimates and forecasts
                       7.1.2. North America market, by location of testing, revenue (USD Billion)
                            7.1.2.1. U.S. market estimates and forecasts
                            7.1.2.2. Canada market estimates and forecasts
                       7.1.3. North America market, by testing device, revenue (USD Billion)
                            7.1.3.1. U.S. market estimates and forecasts
                            7.1.3.2. Canada market estimates and forecasts
                    7.2. Europe
                       7.2.1. Europe market, by type, revenue (USD Billion)
                            7.2.1.1. Sweden market estimates and forecasts
                            7.2.1.2. Germany market estimates and forecasts
                       7.2.2. Europe market, by location of testing, revenue (USD Billion)
                            7.2.2.1. Sweden market estimates and forecasts
                            7.2.2.2. Germany market estimates and forecasts
                       7.2.3. Europe market, by testing device, revenue (USD Billion)
                            7.2.3.1. Sweden market estimates and forecasts
                            7.2.3.2. Germany market estimates and forecasts
                    7.3. Asia Pacific
                       7.3.1. Asia Pacific market, by type, revenue (USD Billion)
                            7.3.1.1. China market estimates and forecasts
                            7.3.1.2. India market estimates and forecasts
                       7.3.2. Asia Pacific market, by location of testing, revenue (USD Billion)
                            7.3.2.1. China market estimates and forecasts
                            7.3.2.2. India market estimates and forecasts
                       7.3.3. Asia Pacific market, by testing device, revenue (USD Billion)
                            7.3.3.1. China market estimates and forecasts
                            7.3.3.2. India market estimates and forecasts
                    7.4. Latin America
                       7.4.1. Latin America market, by type, revenue (USD Billion)
                            7.4.1.1. Brazil market estimates and forecasts
                            7.4.1.2. Mexico market estimates and forecasts
                       7.4.2. Latin America market, by location of testing, revenue (USD Billion)
                            7.4.2.1. Brazil market estimates and forecasts
                            7.4.2.2. Mexico market estimates and forecasts
                       7.4.3. Latin America market, by testing device, revenue (USD Billion)
                            7.4.3.1. Brazil market estimates and forecasts
                            7.4.3.2. Mexico market estimates and forecasts
                    7.5. MEA
                       7.5.1. MEA market, by type, revenue (USD Billion)
                            7.5.1.1. South Africa market estimates and forecasts
                       7.5.2. MEA market, by location of testing, revenue (USD Billion)
                            7.5.2.1. South Africa market estimates and forecasts
                       7.5.3. MEA market, by testing device, revenue (USD Billion)
                            7.5.3.1. South Africa market estimates and forecasts
Chapter 8. Competitive Landscape
                    8.1. Becton Dickinson and company
                       8.1.1. Company Overview
                       8.1.2. Financial Performance
                       8.1.3. Product Benchmarking
                       8.1.4. Strategic Initiatives
                    8.2. Roche Holdings AG
                       8.2.1. Company Overview
                       8.2.2. Financial Performance
                       8.2.3. Product Benchmarking
                       8.2.4. Strategic Initiatives
                    8.3. Hologic Inc.
                       8.3.1. Company Overview
                       8.3.2. Financial Performance
                       8.3.3. Product Benchmarking
                       8.3.4. Strategic Initiatives
                    8.4. BioMerieux
                       8.4.1. Company Overview
                       8.4.2. Financial Performance
                       8.4.3. Product Benchmarking
                       8.4.4. Strategic Initiatives
                    8.5. Alere Inc.
                       8.5.1. Company Overview
                       8.5.2. Financial Performance
                       8.5.3. Product Benchmarking
                       8.5.4. Strategic Initiatives
                    8.6. Danaher Corporation
                       8.6.1. Company Overview
                       8.6.2. Financial Performance
                       8.6.3. Product Benchmarking
                       8.6.4. Strategic Initiatives
                    8.7. Abbott Laboratories
                       8.7.1. Company Overview
                       8.7.2. Financial Performance
                       8.7.3. Product Benchmarking
                       8.7.4. Strategic Initiatives
                    8.8. Affymetrix
                       8.8.1. Company Overview
                       8.8.2. Financial Performance
                       8.8.3. Product Benchmarking
                       8.8.4. Strategic Initiatives
                    8.9. DiaSorin
                       8.9.1. Company Overview
                       8.9.2. Financial Performance
                       8.9.3. Product Benchmarking
                       8.9.4. Strategic Initiatives
                    8.10. Cepheid Inc.
                       8.10.1. Company Overview
                       8.10.2. Financial Performance
                       8.10.3. Product Benchmarking
                       8.10.4. Strategic Initiatives
                    8.11. Orasure
                       8.11.1. Company Overview
                       8.11.2. Financial Performance
                       8.11.3. Product Benchmarking
                       8.11.4. Strategic Initiatives

List of Tables

1. STD diagnostics - Industry Snapshot
2. STD diagnostics market by type, 2012 - 2022 (USD billion)
3. STD diagnostics market by location of testing, 2012 - 2022 (USD billion)
4. STD diagnostics market by testing device, 2012 - 2022 (USD billion)
5. STD diagnostics market by region, 2012 - 2022 (USD billion)
6. STD diagnostics market - Key Market Drivers Analysis
7. STD diagnostics market - Key Market Restraints Analysis
8. North America STD diagnostics market by type, 2012 - 2022 (USD billion)
9. North America STD diagnostics market by location of testing, 2012 - 2022 (USD billion)
10. North America STD diagnostics market by testing device, 2012 - 2022 (USD billion)
11. Europe STD diagnostics market, by type, 2012 - 2022 (USD billion)
12. Europe STD diagnostics market by location of testing, 2012 - 2022 (USD billion)
13. Europe STD diagnostics market by testing device, 2012 - 2022 (USD billion)
14. Asia Pacific STD diagnostics market, by type, 2012 - 2022 (USD billion)
15. Asia Pacific STD diagnostics market by location of testing, 2012 - 2022 (USD billion)
16. Asia Pacific STD diagnostics market by testing device, 2012 - 2022 (USD billion)
17. Latin America STD diagnostics market by type, 2012 - 2022 (USD billion)
18. Latin America STD diagnostics market by location of testing, 2012 - 2022 (USD billion)
19. Latin America STD diagnostics market by testing device, 2012 - 2022 (USD billion)
20. MEA STD diagnostics market by type, 2012 - 2022 (USD billion)
21. MEA STD diagnostics market by location of testing, 2012 - 2022 (USD billion)
22. MEA STD diagnostics market by testing device, 2012 - 2022 (USD billion)

List of Figures

1. STD diagnostics market segmentation
2. Global STD diagnostics market revenue, 2012 - 2022
3. STD diagnostics market dynamics
4. Key opportunities prioritized
5. STD diagnostics market Analysis - Porter's
6. STD diagnostics market Analysis - PESTEL Analysis
7. Global STD diagnostics market by type,2012 - 2022 (USD billion)
8. Chlamydia testing market,2012 - 2022 (USD billion)
9. Gonorrhea testing market,2012 - 2022 (USD billion)
10. Herpes Simplex Virus testing market,2012 - 2022 (USD billion)
11. Human Papilloma Virus testing market,2012 - 2022 (USD billion)
12. Human Immunodeficiency Virus testing market,2012 - 2022 (USD billion)
13. Chancroid testing market,2012 - 2022 (USD billion)
14. Others market,2012 - 2022 (USD billion)
15. Global STD diagnostics market by location of testing,2012 - 2022 (USD billion)
16. Laboratory testing market,2012 - 2022 (USD billion)
17. Point of care (PoC) testing market,2012 - 2022 (USD billion)
18. Global STD diagnostics market by testing device,2012 - 2022 (USD billion)
19. Laboratory devices market,2012 - 2022 (USD billion)
20. Point of care (PoC) devices market,2012 - 2022 (USD billion)
21. Global STD diagnostics market by region 2012 to 2022 (USD billion)
22. North America market, by type 2012 to 2022 (USD billion)
23. North America market, by location of testing 2012 to 2022 (USD billion)
24. North America market, by testing device 2012 to 2022 (USD billion)
25. Europe Market, by type 2012 to 2022 (USD billion)
26. Europe market, by location of testing 2012 to 2022 (USD billion)
27. Europe market, by testing device 2012 to 2022 (USD billion)
28. Asia Pacific Market, by type 2012 to 2022 (USD billion)
29. Asia Pacific market, by location of testing 2012 to 2022 (USD billion)
30. Asia Pacific market, by testing device 2012 to 2022 (USD billion)
31. Latin America Market, by type 2012 to 2022 (USD billion)
32. Latin America market, by location of testing 2012 to 2022 (USD billion)
33. Latin America market, by testing device 2012 to 2022 (USD billion)
34. MEA Market, by type 2012 to 2022 (USD billion)
35. MEA market, by location of testing 2012 to 2022 (USD billion)
36. MEA market, by testing device 2012 to 2022 (USD billion)